Answers are grounded in this paper and cite their sources.
Future research should focus on identifying the patient, provider, and health system factors associated with ER visits and HAs after chemotherapy for breast cancer, to minimize them and lessen the burden on the health care system.
No takes yet. Share an insight, caveat, or question.
Pittman et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: